Clinical Trials Directory

Trials / Completed

CompletedNCT04491773

Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg for More Than 6 Months

Evaluation of Retinal and Choriocapillary Vascular Changes Using Optical Coherence Tomography Angiography in Patients Undergoing Tadalafil 20mg on Alternative Days for More Than 6 Months: a Single-centre Prospective-control

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
Federico II University · Academic / Other
Sex
Male
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg for more than 6 months, using optical coherence tomography angiography.

Detailed description

Tadalafil is a an inhibitor of the enzyme phosphodiesterase and it works by increasing blood flow to the penis thus promoting the erection. This drug represents an treatment for erectile dysfunction in patients after radical prostatectomy. The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features. The study evaluates the changes in optical coherence tomography angiography features after the somministration of Tadalafil 20 mg orally for more than 6 months.

Conditions

Interventions

TypeNameDescription
DRUGTadalafil 20 MGTo study retinal and choriocapillary features in patients undergoing Tadalafil 20 mg orally, on alternate days, for more than 6 months.

Timeline

Start date
2019-11-01
Primary completion
2020-05-25
Completion
2020-05-30
First posted
2020-07-29
Last updated
2020-07-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04491773. Inclusion in this directory is not an endorsement.